News

Actoverco Pharmaceutical Company

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

The first National Conference on “Health Product Vigilance” was held on the occasion of World Patient Safety Day by the Deputy for Food and Drug

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

Here’s the English translation of that sentence: **The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

Tehran, May 2025 — Actover Pharmaceutical Group participated in the 32nd Iranian Congress of Neurology and Clinical Electrophysiology, presenting a wide range of its neurological

Labor Day Tribute from Actoverco

International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

Eid al-Fitr, a celebration of devotion and righteousness, marks the dawn of divine mercy and the season of harvesting the vibrant fruits of answered prayers.

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

The first session of the AcTrip (Actoverco Thyroid Insight Practice) conference series, organized by Actoverco Pharmaceutical Group, was held with the aim of reviewing the

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

The 6th International Congress on Minimally Invasive Techniques in Gynecology, Obstetrics, and Endometriosis took place from January 23 to 25 at Abureihan Hall, Shahid Beheshti

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

The scientific seminar on the effects of hormone replacement therapy (HRT) during menopause, introducing Gynati and Prequin drugs by Ati Pharmed Pharmaceutical Company, was held.

Holding the 21st MS Congress of Iran with the participation of Actoverco

The 21st MS Congress of Iran was held from December 4th to 6th, 2024, and organized by the Multiple Sclerosis Research Center of Tehran University

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

The 24th Congress of Gastrointestinal and Liver Diseases was held with the support of Actover Pharmaceutical Group.